Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05965713 · ClinicalTrials.gov registry record · NA
National Fully Remote Use of IpsiHand Device in Hemiparetic Stroke
A NA study, sponsored by Neurolutions.
- Completed
- Registry status
- NA
- Development phase
- 109
- Enrollment target
NCT05965713: Completed NA study, sponsored by Neurolutions.
NCT05965713 is a NA study that has completed, run by Neurolutions. The registered enrollment target is 109 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05965713, a NA study, has completed, sponsored by Neurolutions.
- COMPLETED
- Registry status
- NA
- Development phase
- 109 participants
- Enrollment target
Study Summary
The goal of this study is to define the efficacy of fully remote home-based BCI therapy in chronic hemiparetic subcortical stroke patients. A randomized controlled study using the integrated remote BCI system will be tested against standard exercise therapy to determine the efficacy of motor improvement in chronic stroke patients with an upper extremity hemiparesis. Specifically, the integrated BCI system will include 1) the remote screening and motor assessment system for the upper extremity and 2) the BCI-controlled robotic hand exoskeleton (i.e. IpsiHand).
Interventions
- DEVICE Neurolutions IpsiHand System
- OTHER Standard of Care - Home Exercise Program for Upper Extremity
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 109 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2025-10-30 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05965713
The ClinicalTrials.gov registry entry for NCT05965713 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 109 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Neurolutions, which has 2 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Neurolutions IpsiHand System is the first listed.
NCT05965713 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05965713 about?
NCT05965713 is a clinical study titled "National Fully Remote Use of IpsiHand Device in Hemiparetic Stroke". The goal of this study is to define the efficacy of fully remote home-based BCI therapy in chronic hemiparetic subcortical stroke patients. A randomized controlled study using the integrated remote BCI system will be tested against standard exercise therapy to determine the efficacy of motor improve...
What is the current status of trial NCT05965713?
This trial is currently completed. It is a NA study. The enrollment target is 109 participants. The study started on 2023-10-01. Estimated completion is 2025-10-30.
What interventions are being tested in trial NCT05965713?
The interventions under investigation include: Neurolutions IpsiHand System (DEVICE), Standard of Care - Home Exercise Program for Upper Extremity (OTHER).
Who is sponsoring clinical trial NCT05965713?
This trial is sponsored by Neurolutions, which has 2 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.